secwatch.observer — SEC 8-K summary
======================================

Issuer:     NEUROONE MEDICAL TECHNOLOGIES Corp (NMTC)
CIK:        0001500198
Form:       8-K
Filed at:   2022-12-22T23:59:59+00:00
Accession:  0001213900-22-081976
Event type: earnings
Sentiment:  neutral
Materiality: 0.70
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

NeuroOne reports fiscal Q4 2022 net loss of $1.4M; collaboration revenue jumps to $1.94M
--------------------------------------------------------------------------------

- Product revenue $69K in Q4 vs $48K prior year; full year $171K vs $178K.
- Collaboration revenue $1.94M in Q4 from Zimmer Development Agreement, up from $5K.
- Net loss $1.4M in Q4 vs $2.6M prior year; full year net loss $10.0M vs $9.9M.
- Cash and short-term investments $11.1M at Sept. 30, 2022, up from $6.9M; no debt outstanding.
- Operating expenses $3.3M in Q4 vs $2.6M; R&D $1.4M, SG&A $1.9M.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1500198/000121390022081976/0001213900-22-081976-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1500198/000121390022081976/ea170126-8k_neuroone.htm
  HTML page:      https://secwatch.observer/filing/0001213900-22-081976

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer